Nature's One received a "no further questions" letter from the FDA regarding its pre-market notification to sell organic infant formula in the United States....
Phagenesis Ltd, announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx Neurostimulation System, a first-of-its-kind...
The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and...
The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) hosted an all-day workshop and annual meeting September 13 and 14 in Washington. The...
